Taiwan's Academic Sinica has synthesized monoclonal antibodies that are able to identify the protein of SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), an important step in the direction of producing a rapid screening reagent for the fast spreading pathogenic virus.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Sports
Taiwan's tennis star Hsieh falls short in Dubai women's doubles final
02/23/2025 01:02 PM - Society
Taiwan headline news
02/23/2025 11:03 AM - Society
Cold air mass brings rain to northern Taiwan
02/23/2025 10:45 AM - Sports
Taiwan keeps WBC hopes alive with 9-1 win over South Africa
02/22/2025 10:40 PM - Business
Confidence in local economy mixed in February: Poll
02/22/2025 08:42 PM